Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development

Oncology Research

Volumn 18, Issue 2-3, 2009, Pages 65-71

  Naidu, Rakesh ^a   Har, Y C ^b,c   Taib, N A ^b,c  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Breast cancer; Fibroblast growth factor receptor 4 (FGFR4); Polymorphism

Indexed keywords

ARGININE; GLYCINE; FGFR4 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 4;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; FGFR4 GENE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALAYSIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; AGED; BREAST TUMOR; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RISK FACTORS;

EID: 75649106849     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789954609     Document Type: Article

References (28)

1. Burke, D.; Wilkes, D.; Blundell, T. L.; Malcolm, S. Fibroblast growth factor receptors: Lessons from the genes. Trends Biochem. Sci. 23:59-62; 1998.
2. Powers, C. J.; McLeskey, S. W.; Wellstein, A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7:165-197; 2000.
3. Bange, J.; Prechtl, D.; Cheburkin, Y.; Specht, K.; Harbeck, N.; Schmitt, M.; Knyazeva, T.; Müller, S.; Gärtner, S.; Sures, I.; Wang, H.; Imyanitov, E.; Häring, H. U.; Knayzev, P.; Iacobelli, S.; Höfler, H.; Ullrich, A. Cancer progression and tumors cell motility are associated with the FGFR4 Arg388 allele. Cancer Res. 62:840-847; 2002.
4. Thussbas, C.; Nahrig, J.; Sreit, S.; Bange, J.; Kriner, M.; Kates, R.; Ulm, K.; Kiechle, M.; Hoefler, H.; Ullrich, A.; Harbeck, N. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J. Clin. Oncol. 24:3747-3755; 2006.
5. Spinola, M.; Leoni, V.; Tanuma, J.; Pettinicchio, A.; Frattini, M.; Signoroni, S.; Agresti, R.; Giovanazzi, R.; Pilotti, S.; Bertario, L.; Ravagnani, F.; Dragani, T. A. FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncol. Rep. 14:415-419; 2005.
6. Jezequiel, P.; Campion, L.; Joalland, M.-P.; Millour, M.; Dravet, F.; Classe, J.-M.; Delacroix, V.; Deporte, R.; Fumoleau, P.; Ricolleau, G. G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br. J. Cancer 90:189-193; 2004.
7. Becker, N.; Nieters, A.; Chang-Claude, J. The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer. Cancer Epidemiol. Biomarkers Prev. 12:582-583; 2003.
8. Morimoto, Y.; Ozaki, T.; Ouchida, M.; Umehara, N.; Ohata, N.; Yoshida, A.; Shimizu, K.; Inoue, H. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma. Cancer 98:2245-2250; 2003.
9. Nakamura, N.; Iijima, T.; Mase, K.; Furuya, S.; Kano, J.; Morishita, Y.; Noguchi, M. Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue. Cancer Sci. 95:226-232; 2004.
10. Wang, J.; Stockton, D. W.; Ittmann, M. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin. Cancer Res. 10:6169-6178; 2004.
11. da Costa Andrade, V. C.; Parise, Jr., O.; Pereira Hors, C.; de Melo Martins, P. C.; Silva, A. P.; Garicochea, B. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Exp. Mol. Pathol. 82:53-57; 2007.
12. Spinola, M.; Leoni, V.; Pignatiello, C.; Conti, B.; Ravagnani, F.; Pastorino, U.; Dragani, T. A. Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients. J. Clin. Oncol. 23:7307-7311; 2005.
13. Streit, S.; Bange, J.; Fichtner, A. S.; Ihrler, S.; Issing, W.; Ullrich, A. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Int. J. Cancer 111:213-217; 2004.
14. Streit, S.; Mestel, D. S.; Schmidt, M.; Ullrich, A.; Berking, C. FGFR4 Arg388 allele correlates with tumor thickness and FGFR4 protein expression with survival of melanoma patients. Br. J. Cancer 94:1879-1886; 2006.
15. Matakidou, A.; el Galta, R.; Rudd, M. F.; Webb, E. L.; Bridle, H.; Eisen, T.; Houlston, R. S.; GELCAPS Consortium. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. Br. J. Cancer 96:1904-1907; 2007.
16. Mawrina, C.; Kirchesa, E.; Dieteb, S.; Wiedemannb, F. R.; Schneiderc, T.; Firschingc, R.; Kropfd, S.; Bogertse, B.; Vorwerkf, C. K.; Krügerg, S.; Dietzmanna, K. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas. Cancer Lett. 239:239-245; 2006.
17. Yang, Y. C.; Lu, M. L.; Rao, J. Y.; Wallerand, H.; Cai, L.; Cao, W.; Pantuck, A.; Dalbagni, G.; Reuter, V.; Figlin, R. A.; Belldegrun, A.; Cordon-Cardo, C.; Zhang, Z. F. Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis. Br. J. Cancer 95:1455-1458; 2006.
18. Leung, H. Y.; Gullick, W. J.; Lemoine, N. R. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int. J. Cancer 59:667-675; 1994.
19. Jaakkola, S.; Salmikangas, P.; Nylund, S.; Partanen, J.; Armstrong, E.; Pyrhonen, S.; Lehtovirta, P.; Nevanlinna, H. Amplification of fgfr4 gene in human breast and gynecological cancers. Int. J. Cancer 54:378-382; 1993.
20. Takahashi, A.; Sasaki, H.; Kim, S. J.; Kakizoe, T.; Miyao, N.; Sugimura, T.; Terada, M.; Tsukamoto, T. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem. Biophys. Res. Commun. 257:855-859; 1999.
21. Cavallaro, U.; Christofori, G. Multitasking in tumor progression: Signaling functions of cell adhesion molecules. Ann. NY Acad. Sci. 1014:58-66; 2004.
22. Lim, G. C. C.; Halimah, Y. Second report of the National Cancer Registry. Cancer incidence in Malaysia 2003. Kuala Lumpur: National Cancer Registry; 2004.
23. Elston, C. W.; Ellis, I. O. Pathological prognostic factors in breast cancer I. Histopathology 19:403-410; 1991.
24. Bloom, H. I. G.; Richardson, W. W. Histological grading and prognosis. Br. J. Cancer 11:359-377; 1957.
25. Breast. AJCC cancer staging manual. In: American Joint Committee on Cancer, 6th ed. New York: Springer; 2002:171-180.
26. Singletary, E.; Allred, C.; Ashley, P.; Bassett, L.; Berry, D.; Bland, K.; Borgen, C.; Edge, B.; Hayes, D.; Hughes, L.; Hutter, R.; Morrow, M.; Page, D.; Recht, A.; Theriault, R.; Thor, A.; Weaver, D.; Wieland, S.; Greene, F. Revision of the American Joint Committee on Cancer staging system for breast cancer. J. Clin. Oncol. 20:3628-3636; 2002.
27. Naidu, R.; Har, Y. C.; Taib, N. A. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J. Exp. Clin. Cancer Res. 26:133-140; 2007.
28. Stadler, C. R.; Knyazev, P.; Bange, J.; Ullrich, A. FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cell. Signal. 18:783-794; 2006.